(Q40311168)

19 September 2017

title

A molecular signature of PCA3 and ERG exosomal RNA from non-DRE urine is predictive of initial prostate biopsy result (English)

1 reference

19 September 2017

J Skog

5

0 references

author name string

M J Donovan

1

1 reference

19 September 2017

M Noerholm

2

1 reference

19 September 2017

S Bentink

3

1 reference

19 September 2017

S Belzer

4

1 reference

19 September 2017

V O'Neill

6

1 reference

19 September 2017

J S Cochran

7

1 reference

19 September 2017

G A Brown

8

1 reference

19 September 2017

language of work or name

1 reference

8 September 2015

1 reference

Prostate Cancer and Prostatic Diseases

19 September 2017

published in

1 reference

19 September 2017

volume

18

1 reference

19 September 2017

issue

4

1 reference

19 September 2017

page(s)

370-375

1 reference

19 September 2017

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Optimization of prostate biopsy: review of technique and complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Nationwide population based study of infections after transrectal ultrasound guided prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Prosbiotate: a multicenter, prospective analysis of infectious complications after prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

When is prostate cancer really cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Active surveillance versus radical treatment for favorable-risk localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Systematic review of complications of prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Radical prostatectomy or watchful waiting in early prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Radical prostatectomy versus observation for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Brain tumor microvesicles: insights into intercellular communication in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Massively parallel sequencing of human urinary exosome/microvesicle RNA reveals a predominance of non-coding RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

TMPRSS2-ERG Fusion Gene Expression in Prostate Tumor Cells and Its Clinical and Biological Significance in Prostate Cancer Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Evaluation of the ETS-related gene mRNA in urine for the detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Prostate cancer biomarker profiles in urinary sediments and exosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

High SPDEF may identify patients who will have a prolonged response to androgen deprivation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Quantitative analysis of ERG expression and its splice isoforms in formalin-fixed, paraffin-embedded prostate cancer samples: association with seminal vesicle invasion and biochemical recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

A Comparative Study of ERG Status Assessment on DNA, mRNA, and Protein Levels Using Unique Samples from a Swedish Biopsy Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.40

Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26345389

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/PCAN.2015.40

1 reference

Dimensions Publication ID

19 September 2017

1026752764

0 references

1 reference